Verici Dx plc (LON:VRCI – Get Free Report) was down 2.8% on Wednesday . The stock traded as low as GBX 0.70 and last traded at GBX 0.71. Approximately 600,638 shares changed hands during trading, a decline of 14% from the average daily volume of 700,879 shares. The stock had previously closed at GBX 0.73.
Verici Dx Stock Performance
The company has a debt-to-equity ratio of 4.64, a quick ratio of 8.49 and a current ratio of 4.54. The company has a 50 day moving average price of GBX 0.76 and a 200 day moving average price of GBX 0.70. The company has a market capitalization of £10.67 million, a price-to-earnings ratio of -0.24 and a beta of 1.59.
About Verici Dx
Verici Dx is a developer of a complementary suite of leading-edge tests forming a kidney transplant platform for personalised patient and organ response risk to assist clinicians in medical management for improved patient outcomes. The underlying technology is based upon artificial intelligence assisted transcriptomic analysis to provide RNA signatures focused upon the immune response and other biological pathway signals critical for transplant prognosis of risk of injury, rejection and graft failure from pre-transplant to late stage.
See Also
- Five stocks we like better than Verici Dx
- A month before the crash
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Wall Street Alert: Buy AES
- Bitcoin is down but your income is about to explode
- Trump Devises the Death of the IRS ☠️
Receive News & Ratings for Verici Dx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verici Dx and related companies with MarketBeat.com's FREE daily email newsletter.
